Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT06312137 |
| Title | A Study to Assess Efficacy and Safety of Pembrolizumab With or Without MK- 2870 in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mid Florida Hematology and Oncology Center ( Site 0018) | RECRUITING | Orange City | Florida | 32763 | United States | Details |
| Rambam Health Care Campus-Oncology Division ( Site 2203) | RECRUITING | Haifa | 3109601 | Israel | Details | |
| Shaare Zedek Medical Center ( Site 2206) | RECRUITING | Jerusalem | 9103102 | Israel | Details | |
| Rabin Medical Center ( Site 2204) | RECRUITING | Petah Tikva | 4941 492 | Israel | Details | |
| National Cheng Kung University Hospital-Clinical Trial Center ( Site 1102) | RECRUITING | Tainan | 704 | Taiwan | Details |